Marfan syndrome. 2015. Billable Thru Sept 30/2015. Non-Billable On/After Oct 1/2015. ICD-9-CM 759.82 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 759.82 should only be used for claims with a date of service on or before September 30, 2015. For claims with a date of service on or after ...
Marfan syndrome ICD-9-CM 759.82 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 759.82 should only be used for claims with a date of service on or before September 30, 2015. For claims with a date of service on or after October 1, 2015, use an equivalent ICD-10-CM code (or codes).
ICD-9 Code 759.82 Marfan syndrome. ICD-9 Index; Chapter: 740–759; Section: 740-759; Block: 759 Other and unspecified congenital anomalies; 759.82 - Marfan syndrome
Marfan syndrome (759.82) ICD-9 code 759.82 for Marfan syndrome is a medical classification as listed by WHO under the range -CONGENITAL ANOMALIES (740-759). Subscribe to Codify and get the code details in a flash.
Marfan syndrome | |
---|---|
Other names | Marfan's syndrome |
Ectopia lentis in Marfan syndrome: Zonular fibers are seen. | |
Specialty | Medical genetics |
Symptoms | Tall, thin build; long arms, legs and fingers; flexible fingers and toes |
Marfan syndrome (ICD-9-CM code 759.82) is a genetic disorder affecting the connective tissue, causing it to lose its elasticity and strength. Since connective tissue is located throughout the body, the syndrome can affect many different body systems, such as the cardiovascular, nervous, and respiratory. Marfan syndrome is an autosomal dominant ...
The greatest risk factor is having a parent with the disorder. Another cause is a change in a gene that occurs during early development in the womb.
Treatment. There is no cure for Marfan syndrome. However, a physician may treat the symptoms and attempt to prevent the complications. Treatment for the cardiovascular complications may include medications such as beta blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and calcium channel blockers.
The syndrome is present at birth but may not appear until later in life. According to coding guidelines, “Although present at birth, a congenital a nomaly may not be identified until later in life. Whenever the condition is diagnosed by the physician, it is appropriate to assign a code from codes 740-759” (ICD-9-CM Official Guidelines for Coding and Reporting, effective October 1, 2009, page 54). Therefore, it is appropriate to assign the congenital code 759.82 in an adult patient.
In addition, surgery may be required on the heart valves or aorta. Coding and sequencing for Marfan syndrome are dependent on the physician documentation in the medical record and application of the Official Coding Guidelines for inpatient care.
Marfan syndrome is associated with mutations in the gene encoding fibrillin, a major element of extracellular microfibrils of connective tissue. Disorder of connective tissue characterized by tall stature, elongated extremities, subluxation of the lens, dilatation of the ascending aorta, and "pigeon breast"; inherited as an autosomal dominant trait.
The 2022 edition of ICD-10-CM Q87.4 became effective on October 1, 2021.
A hereditary disorder of connective tissue characterized by tall stature, elongated extremities, dilatation of the ascending aorta, and pigeon breast. An autosomal dominant disorder of connective tissue with abnormal features in the heart, the eye, and the skeleton. Cardiovascular manifestations include mitral valve prolapse, dilation of the aorta, ...
Marfan syndrome can be mild to severe, and the symptoms can vary. People with marfan syndrome are often very tall, thin and loose jointed. Most people with marfan syndrome have heart and blood vessel problems, such as a weakness in the aorta or heart valves that leak.
Marfan syndrome is a disorder that affects connective tissue.
The 2022 edition of ICD-10-CM Q87.40 became effective on October 1, 2021.
A hereditary disorder of connective tissue characterized by tall stature, elongated extremities, dilatation of the ascending aorta, and pigeon breast. An autosomal dominant disorder of connective tissue with abnormal features in the heart, the eye, and the skeleton.
Clinical Information. A genetic syndrome inherited as an autosomal dominant trait. It is caused by mutations in the fbn1 gene. It is characterized by tall stature, elongated extremities, mitral valve prolapse, aortic dilatation, aortic dissection, and sublaxation of the lens.
Marfan syndrome can be mild to severe, and the symptoms can vary. People with marfan syndrome are often very tall, thin and loose jointed. Most people with marfan syndrome have heart and blood vessel problems, such as a weakness in the aorta or heart valves that leak.